An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

FDA

Livongo, Voluntis partner on diabetes management offering

With FDA nod, Biotronik debuts first coronary stent in U.S.

uniQure details three-pronged gene therapy trial program

Despite deaths and trial halts, Leerink sees Juno positives

Medtronic device gets FDA nod in metastatic bone tumors

Flaws in adverse event reporting kept power morcellators in use

Adverse events prompt FDA warning about obesity devices

FDA lifts clinical hold on Northwest Bio cancer vaccine trial

FDA clears Elekta advanced cervical cancer device for sale

AstraZeneca CEO: We want a ‘strong, science-led FDA’